No effect of ablation of surfactant protein-D on acute cerebral infarction in mice

Journal of Neuroinflammation

Volumn 11, Issue , 2014, Pages

  Lambertsen, Kate L ^a   Østergaard, Kamilla ^a,b   Clausen, Bettina H ^a   Hansen, Søren ^a   Stenvang, Jan ^c   Thorsen, Stine B ^c   Meldgaard, Michael ^a   Kristensen, Bjarne W ^b   Hansen, Pernille B ^a   Sorensen, Grith L ^a   Finsen, Bente ^a  

^a UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^b ODENSE UNIVERSITY HOSPITAL   (Denmark)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Collectins; Macrophages; Microglia; Middle cerebral artery occlusion; Phagocytosis; Plasticity; Stroke; Tumor necrosis factor

Indexed keywords

CYTOKINE; MESSENGER RNA; SURFACTANT PROTEIN D; TUMOR NECROSIS FACTOR; CD11B ANTIGEN; CD45 ANTIGEN; GLIAL FIBRILLARY ACIDIC PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOASSAY; BRAIN ARTERY; BRAIN CELL; BRAIN INFARCTION; BRAIN INFARCTION SIZE; BRAIN ISCHEMIA; BRAIN TISSUE; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENCEPHALITIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MACROGLIA; MALE; MICROGLIA; MIDDLE AGED; MIDDLE CEREBRAL ARTERY OCCLUSION; MOUSE; NONHUMAN; POLYMERASE CHAIN REACTION; PROTEIN BLOOD LEVEL; PROTEIN SYNTHESIS; PROXIMITY LIGATION ASSAY; VERY ELDERLY; YOUNG ADULT; LEUKOCYTE; PROTEIN EXPRESSION; WILD TYPE; ANIMAL; BLOOD; BRAIN; C57BL MOUSE; CEREBRAL ARTERY DISEASE; CEREBRAL INFARCTION; COMPLICATION; DEFICIENCY; DRUG EFFECTS; GENETICS; KNOCKOUT MOUSE; METABOLISM; PATHOLOGY; TIME;

ANIMALS; ANTIGENS, CD11B; ANTIGENS, CD45; BRAIN; CEREBRAL ARTERIES; CEREBRAL INFARCTION; FEMALE; GLIAL FIBRILLARY ACIDIC PROTEIN; HUMANS; INFARCTION, MIDDLE CEREBRAL ARTERY; LEUKOCYTES; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICROGLIA; PULMONARY SURFACTANT-ASSOCIATED PROTEIN D; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84904523167     PISSN: None     EISSN: 17422094     Source Type: Journal    
DOI: 10.1186/1742-2094-11-123     Document Type: Article

References (49)

1. Wert SE, Yoshida M, LeVine AM, Ikegami M, Jones T, Ross GF, Fisher JH, Korfhagen TR, Whitsett JA. Increased metalloproteinase activity, oxidant production, and emphysema in surfactant protein D gene-inactivated mice. Proc Natl Acad Sci U S A 2000, 97:5972-5977. 10.1073/pnas.100448997, 18543, 10801980.
2. Ofek I, Mesika A, Kalina M, Keisari Y, Podschun R, Sahly H, Chang D, McGregor D, Crouch E. Surfactant protein D enhances phagocytosis and killing of unencapsulated phase variants of Klebsiella pneumoniae. Infect Immun 2001, 69:24-33. 10.1128/IAI.69.1.24-33.2001, 97851, 11119485.
3. Wright JR. Immunoregulatory functions of surfactant proteins. Nat Rev Immunol 2005, 5:58-68. 10.1038/nri1528, 15630429.
4. Ohya M, Nishitani C, Sano H, Yamada C, Mitsuzawa H, Shimizu T, Saito T, Smith K, Crouch E, Kuroki Y. Human pulmonary surfactant protein D binds the extracellular domains of Toll-like receptors 2 and 4 through the carbohydrate recognition domain by a mechanism different from its binding to phosphatidylinositol and lipopolysaccharide. Biochemistry 2006, 45:8657-8664. 10.1021/bi060176z, 16834340.
5. Liu CF, Rivere M, Huang HJ, Puzo G, Wang JY. Surfactant protein D inhibits mite-induced alveolar macrophage and dendritic cell activations through TLR signalling and DC-SIGN expression. Clinical Exp Allergy J British Soc Allergy Clinical Immunol 2010, 40:111-122.
6. Yoshida M, Korfhagen TR, Whitsett JA. Surfactant protein D regulates NF-kappa B and matrix metalloproteinase production in alveolar macrophages via oxidant-sensitive pathways. J Immunol 2001, 166:7514-7519. 10.4049/jimmunol.166.12.7514, 11390505.
7. LeVine AM, Whitsett JA, Gwozdz JA, Richardson TR, Fisher JH, Burhans MS, Korfhagen TR. Distinct effects of surfactant protein A or D deficiency during bacterial infection on the lung. J Immunol 2000, 165:3934-3940. 10.4049/jimmunol.165.7.3934, 11034401.
8. Fujita M, Shannon JM, Ouchi H, Voelker DR, Nakanishi Y, Mason RJ. Serum surfactant protein D is increased in acute and chronic inflammation in mice. Cytokine 2005, 31:25-33. 10.1016/j.cyto.2005.02.006, 15967375.
9. Sorensen GL, Madsen J, Kejling K, Tornoe I, Nielsen O, Townsend P, Poulain F, Nielsen CH, Reid KB, Hawgood S, Falk E, Holmskov U. Surfactant protein D is proatherogenic in mice. Am J Physiol Heart Circ Physiol 2006, 290:H2286-H2294. 10.1152/ajpheart.01105.2005, 16387789.
10. Madsen J, Kliem A, Tornoe I, Skjodt K, Koch C, Holmskov U. Localization of lung surfactant protein D on mucosal surfaces in human tissues. J Immunol 2000, 164:5866-5870. 10.4049/jimmunol.164.11.5866, 10820266.
11. Snyder GD, Oberley-Deegan RE, Goss KL, Romig-Martin SA, Stoll LL, Snyder JM, Weintraub NL. Surfactant protein D is expressed and modulates inflammatory responses in human coronary artery smooth muscle cells. Am J Physiol Heart Circ Physiol 2008, 294:H2053-H2059. 10.1152/ajpheart.91529.2007, 3146313, 18359891.
12. Lee MY, Sorensen GL, Holmskov U, Vanhoutte PM. The presence and activity of SP-D in porcine coronary endothelial cells depend on Akt/PI3K, Erk and nitric oxide and decrease after multiple passaging. Mol Immunol 2009, 46:1050-1057. 10.1016/j.molimm.2008.09.027, 19010548.
13. Mocco J, Mack WJ, Ducruet AF, Sosunov SA, Sughrue ME, Hassid BG, Nair MN, Laufer I, Komotar RJ, Claire M, Holland H, Pinsky DJ, Connolly ES. Complement component C3 mediates inflammatory injury following focal cerebral ischemia. Circ Res 2006, 99:209-217. 10.1161/01.RES.0000232544.90675.42, 16778128.
14. Veerhuis R, Nielsen HM, Tenner AJ. Complement in the brain. Mol Immunol 2011, 48:1592-1603. 10.1016/j.molimm.2011.04.003, 3142281, 21546088.
15. Yanamadala V, Friedlander RM. Complement in neuroprotection and neurodegeneration. Trends Mol Med 2010, 16:69-76. 10.1016/j.molmed.2009.12.001, 2824068, 20116331.
16. Orsini F, Villa P, Parrella S, Zangari R, Zanier ER, Gesuete R, Stravalaci M, Fumagalli S, Ottria R, Reina JJ, Paladini A, Micotti E, Ribeiro-Viana R, Rojo J, Pavlov VI, Stahl GL, Bernardi A, Gobbi M, De Simoni MG. Targeting mannose-binding lectin confers long-lasting protection with a surprisingly wide therapeutic window in cerebral ischemia. Circulation 2012, 126:1484-1494. 10.1161/CIRCULATIONAHA.112.103051, 3478764, 22879370.
17. Osthoff M, Katan M, Fluri F, Schuetz P, Bingisser R, Kappos L, Steck AJ, Engelter ST, Mueller B, Christ-Crain M, Trendelenburg M. Mannose-binding lectin deficiency is associated with smaller infarction size and favorable outcome in ischemic stroke patients. PLoS One 2011, 6:e21338. 10.1371/journal.pone.0021338, 3119675, 21712986.
18. Cervera A, Planas AM, Justicia C, Urra X, Jensenius JC, Torres F, Lozano F, Chamorro A. Genetically-defined deficiency of mannose-binding lectin is associated with protection after experimental stroke in mice and outcome in human stroke. PLoS One 2010, 5:e8433. 10.1371/journal.pone.0008433, 2815773, 20140243.
19. Nybo M, Andersen K, Sorensen GL, Lolk A, Kragh-Sorensen P, Holmskov U. Serum surfactant protein D is correlated to development of dementia and augmented mortality. Clin Immunol 2007, 123:333-337. 10.1016/j.clim.2007.03.001, 17449329.
20. Tu XK, Yang WZ, Shi SS, Wang CH, Zhang GL, Ni TR, Chen CM, Wang R, Jia JW, Song QM. Spatio-temporal distribution of inflammatory reaction and expression of TLR2/4 signaling pathway in rat brain following permanent focal cerebral ischemia. Neurochem Res 2010, 35:1147-1155. 10.1007/s11064-010-0167-6, 20386979.
21. Janssen WJ, McPhillips KA, Dickinson MG, Linderman DJ, Morimoto K, Xiao YQ, Oldham KM, Vandivier RW, Henson PM, Gardai SJ. Surfactant proteins A and D suppress alveolar macrophage phagocytosis via interaction with SIRP alpha. Am J Respir Crit Care Med 2008, 178:158-167. 10.1164/rccm.200711-1661OC, 2453510, 18420961.
22. Gardai SJ, Xiao YQ, Dickinson M, Nick JA, Voelker DR, Greene KE, Henson PM. By binding SIRPalpha or calreticulin/CD91, lung collectins act as dual function surveillance molecules to suppress or enhance inflammation. Cell 2003, 115:13-23. 10.1016/S0092-8674(03)00758-X, 14531999.
23. Wang L, Lu Y, Deng S, Zhang Y, Yang L, Guan Y, Matozaki T, Ohnishi H, Jiang H, Li H. SHPS-1 deficiency induces robust neuroprotection against experimental stroke by attenuating oxidative stress. J Neurochem 2012, 122:834-843. 10.1111/j.1471-4159.2012.07818.x, 22671569.
24. Botas C, Poulain F, Akiyama J, Brown C, Allen L, Goerke J, Clements J, Carlson E, Gillespie AM, Epstein C, Hawgood S. Altered surfactant homeostasis and alveolar type II cell morphology in mice lacking surfactant protein D. Proc Natl Acad Sci U S A 1998, 95:11869-11874. 10.1073/pnas.95.20.11869, 21732, 9751757.
25. Sorensen GL, Hjelmborg JB, Kyvik KO, Fenger M, Hoj A, Bendixen C, Sorensen TI, Holmskov U. Genetic and environmental influences of surfactant protein D serum levels. Am J Physiol Lung Cell Mol Physiol 2006, 290:L1010-L1017. 10.1152/ajplung.00487.2005, 16361352.
26. Gregersen R, Lambertsen K, Finsen B. Microglia and macrophages are the major source of tumor necrosis factor in permanent middle cerebral artery occlusion in mice. J Cereb Blood Flow Metab 2000, 20:53-65. 10.1097/00004647-200001000-00009, 10616793.
27. Lambertsen KL, Gregersen R, Drojdahl N, Owens T, Finsen B. A specific and sensitive method for visualization of tumor necrosis factor in the murine central nervous system. Brain Res Brain Res Protoc 2001, 7:175-191. 10.1016/S1385-299X(01)00062-9, 11356385.
28. Moller HE, Gaupp A, Vestring T, Dietl KH, Vermathen P, Buchholz B, Peters PE. Kinetics of metabolism in human kidney transplants measured by dynamic 31P NMR spectroscopy. Z Naturforsch C 1995, 50:439-450.
29. Lin TN, He YY, Wu G, Khan M, Hsu CY. Effect of brain edema on infarct volume in a focal cerebral ischemia model in rats. Stroke J Cereb Circulat 1993, 24:117-121.
30. Lambertsen KL, Clausen BH, Babcock AA, Gregersen R, Fenger C, Nielsen HH, Haugaard LS, Wirenfeldt M, Nielsen M, Dagnaes-Hansen F, Bluethmann H, Faergeman NJ, Meldgaard M, Deierborg T, Finsen B. Microglia protect neurons against ischemia by synthesis of tumor necrosis factor. J Neurosci 2009, 29:1319-1330. 10.1523/JNEUROSCI.5505-08.2009, 19193879.
31. Clausen BH, Lambertsen KL, Babcock AA, Holm TH, Dagnaes-Hansen F, Finsen B. Interleukin-1beta and tumor necrosis factor-alpha are expressed by different subsets of microglia and macrophages after ischemic stroke in mice. J Neuroinflammation 2008, 5:46. 10.1186/1742-2094-5-46, 2585073, 18947400.
32. Meldgaard M, Fenger C, Lambertsen KL, Pedersen MD, Ladeby R, Finsen B. Validation of two reference genes for mRNA level studies of murine disease models in neurobiology. J Neurosci Methods 2006, 156:101-110. 10.1016/j.jneumeth.2006.02.008, 16554095.
33. Dissing-Olesen L, Thaysen-Andersen M, Meldgaard M, Hojrup P, Finsen B. The function of the human interferon-beta 1a glycan determined in vivo. J Pharmacol Exp Ther 2008, 326:338-347. 10.1124/jpet.108.138263, 18445781.
34. Clausen BH, Lambertsen KL, Meldgaard M, Finsen B. A quantitative in situ hybridization and polymerase chain reaction study of microglial-macrophage expression of interleukin-1beta mRNA following permanent middle cerebral artery occlusion in mice. Neuroscience 2005, 132:879-892. 10.1016/j.neuroscience.2005.01.031, 15857694.
35. Hansen S, Schmidt V, Steffensen MA, Jensen PH, Gjerstorff M, Thiel S, Holmskov U. An enzyme-linked immunosorbent assay (ELISA) for quantification of mouse surfactant protein D (SP-D). J Immunol Methods 2008, 330:75-85. 10.1016/j.jim.2007.11.001, 18078951.
36. Campanella M, Sciorati C, Tarozzo G, Beltramo M. Flow cytometric analysis of inflammatory cells in ischemic rat brain. Stroke 2002, 33:586-592. 10.1161/hs0202.103399, 11823674.
37. Zehntner SP, Brickman C, Bourbonniere L, Remington L, Caruso M, Owens T. Neutrophils that infiltrate the central nervous system regulate T cell responses. J Immunol 2005, 174:5124-5131. 10.4049/jimmunol.174.8.5124, 15814744.
38. Lundberg M, Eriksson A, Tran B, Assarsson E, Fredriksson S. Homogeneous antibody-based proximity extension assays provide sensitive and specific detection of low-abundant proteins in human blood. Nucleic Acids Res 2011, 39:e102. 10.1093/nar/gkr424, 3159481, 21646338.
39. Brambilla R, Couch Y, Lambertsen KL. The effect of stroke on immune function. Mol Cell Neurosci 2013, 53:26-33.
40. Macrez R, Ali C, Toutirais O, Le Mauff B, Defer G, Dirnagl U, Vivien D. Stroke and the immune system: from pathophysiology to new therapeutic strategies. Lancet Neurol 2011, 10:471-480. 10.1016/S1474-4422(11)70066-7, 21511199.
41. Clark H, Palaniyar N, Strong P, Edmondson J, Hawgood S, Reid KB. Surfactant protein D reduces alveolar macrophage apoptosis in vivo. J Immunol 2002, 169:2892-2899. 10.4049/jimmunol.169.6.2892, 12218102.
42. Motwani M, White RA, Guo N, Dowler LL, Tauber AI, Sastry KN. Mouse surfactant protein-D. cDNA cloning, characterization, and gene localization to chromosome 14. J Immunol 1995, 155:5671-5677.
43. Persson L, Hardemark HG, Bolander HG, Hillered L, Olsson Y. Neurologic and neuropathologic outcome after middle cerebral artery occlusion in rats. Stroke 1989, 20:641-645. 10.1161/01.STR.20.5.641, 2718205.
44. Lambertsen KL, Meldgaard M, Ladeby R, Finsen B. A quantitative study of microglial-macrophage synthesis of tumor necrosis factor during acute and late focal cerebral ischemia in mice. J Cereb Blood Flow Metab 2005, 25:119-135. 10.1038/sj.jcbfm.9600014, 15678118.
45. Krakauer JW, Carmichael ST, Corbett D, Wittenberg GF. Getting neurorehabilitation right: what can be learned from animal models?. Neurorehabil Neural Repair 2012, 26:923-931. 10.1177/1545968312440745, 22466792.
46. Lambertsen KL, Biber K, Finsen B. Inflammatory cytokines in experimental and human stroke. J Cereb Blood Flow Metab 2012, 32:1677-1698. 10.1038/jcbfm.2012.88, 3434626, 22739623.
47. Sorensen GL, Husby S, Holmskov U. Surfactant protein A and surfactant protein D variation in pulmonary disease. Immunobiology 2007, 212:381-416. 10.1016/j.imbio.2007.01.003, 17544823.
48. Gaunsbaek MQ, Rasmussen KJ, Beers MF, Atochina-Vasserman EN, Hansen S. Lung surfactant protein D (SP-D) response and regulation during acute and chronic lung injury. Lung 2013, 191:295-303. 10.1007/s00408-013-9452-x, 23435873.
49. Inacio AR, Bucala R, Deierborg T. Lack of macrophage migration inhibitory factor in mice does not affect hallmarks of the inflammatory/immune response during the first week after stroke. J Neuroinflammation 2011, 8:75. 10.1186/1742-2094-8-75, 3152909, 21714902.